茅台基金等入股康维健生物

Core Viewpoint - Recently, Kangweijian Biopharmaceutical Co., Ltd. has undergone a business change, adding Moutai (Guizhou) High-Quality Growth Equity Investment Partnership (Limited Partnership) as a shareholder [1] Company Overview - Kangweijian Biopharmaceutical Co., Ltd. was established in 2020 and is represented by legal representative Zeng Qiwen [1] - The company's business scope includes research and development of industrial enzyme preparations, import and export of goods, technology import and export, sales of food additives, and medical research and experimental development [1]